TY - JOUR
T1 - Exposure to ZnO/TiO2 nanoparticles affects health outcomes in cosmetics salesclerks
AU - Lee, Ching Chang
AU - Lin, Yi Hsin
AU - Hou, Wen Che
AU - Li, Meng Han
AU - Chang, Jung Wei
N1 - Funding Information:
Funding: This work was supported by grants from the Ministry of Science and Technology (MOST 106-2314-B-010-057-).
Funding Information:
This work was supported by grants from the Ministry of Science and Technology (MOST 106-2314-B-010-057-). Acknowledgments: We would like to thank Yi-Hsin Lin and Meng-Han Li for their assistance in data collection, specimen collection, and method development as well as Wen-Che Hou for his assistance in sample pretreatment and conducting sp-ICP-MS analysis. We are also deeply grateful to the research collaboration of the National Cheng Kung University, Ching-Chang Lee for the support in sampling and data analysis.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Concerns about the effects of nanoparticles (NPs) on human health are being raised by researchers because the risks of nanocosmetics like sunscreen are unknown. We explored the association between urinary oxidative stress markers and exposure of cosmetics salesclerks to 20 cosmetics that might contain titanium dioxide (TiO2)/zinc oxide (ZnO) NPs. We then recruited 40 cosmetics salesclerks and 24 clothing salesclerks and categorized them based on their exposure to ZnO and TiO2 NPs. Nineteen and 15 samples met the EU definition for TiO2 and ZnO nanomaterials, respectively. Participants with a higher co-exposure index of ZnO and TiO2 NPs had a significantly higher base level of urinary 8-hydroxy-2′-deoxyguanosin (8-OHdG) concentrations than the lower co-exposure group (5.82 vs. 2.85 ng/mL, p < 0.001). After potential confounding factors had been adjusted for, the TiO2 and ZnO NP co-exposure index was significantly positively associated with the urinary 8-OHdG base concentration (β = 0.308, 95% CI = 0.106 to 0.510) and the creatinine-adjusted concentration (β = 0.486, 95% CI = 0.017 to 0.954). Current evidence suggests that the likelihood of harm from using sunscreens containing nanoparticles might result in higher urinary 8-OHdG. However, our limited number and types of sample cosmetics might underestimate the risk.
AB - Concerns about the effects of nanoparticles (NPs) on human health are being raised by researchers because the risks of nanocosmetics like sunscreen are unknown. We explored the association between urinary oxidative stress markers and exposure of cosmetics salesclerks to 20 cosmetics that might contain titanium dioxide (TiO2)/zinc oxide (ZnO) NPs. We then recruited 40 cosmetics salesclerks and 24 clothing salesclerks and categorized them based on their exposure to ZnO and TiO2 NPs. Nineteen and 15 samples met the EU definition for TiO2 and ZnO nanomaterials, respectively. Participants with a higher co-exposure index of ZnO and TiO2 NPs had a significantly higher base level of urinary 8-hydroxy-2′-deoxyguanosin (8-OHdG) concentrations than the lower co-exposure group (5.82 vs. 2.85 ng/mL, p < 0.001). After potential confounding factors had been adjusted for, the TiO2 and ZnO NP co-exposure index was significantly positively associated with the urinary 8-OHdG base concentration (β = 0.308, 95% CI = 0.106 to 0.510) and the creatinine-adjusted concentration (β = 0.486, 95% CI = 0.017 to 0.954). Current evidence suggests that the likelihood of harm from using sunscreens containing nanoparticles might result in higher urinary 8-OHdG. However, our limited number and types of sample cosmetics might underestimate the risk.
UR - http://www.scopus.com/inward/record.url?scp=85089655520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089655520&partnerID=8YFLogxK
U2 - 10.3390/ijerph17176088
DO - 10.3390/ijerph17176088
M3 - Article
C2 - 32825657
AN - SCOPUS:85089655520
SN - 1661-7827
VL - 17
SP - 1
EP - 12
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 17
M1 - 6088
ER -